Communiqués

25/01/24 "Exploring Market Opportunities Stocks to Watch Under 5¢ Now: CLNV, ENZC, HNRC, HALB, SPZI" AQ
15/09/23 SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AQ
19/07/23 Exploring Breakthrough Biotech Stocks: ENZC, CYDY, HGEN, HALB AQ
15/05/23 Undervalued Biotech Stocks to Watch After Enzolytics' (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT AQ
22/08/22 Enzolytics : Disclosure Statement June 30, 2022 PU
28/07/22 Enzolytics : Announces the International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies. PU
23/05/22 Enzolytics : Financial Statements and Footnotes 3.31.2022 PU
16/05/22 Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast NE
18/04/22 Enzolytics : FINANCIAL AND FOOTNOTES 12.31.2021 PU
14/04/22 Enzolytics : AMENDED FINANCIALS AND FOOTNOTES DECEMBER31, 2020 PU
01/04/22 Enzolytics : NOTIFICATION OF LATE FILING 2021 ANNUAL FINANCIALS PU
31/03/22 Enzolytics : Annual Disclosure Filing 12.31.2021 PU
25/03/22 Enzolytics : Highlights Its Comprehensive PCT Patent Applications Covering Discovered Conserved Target Epitopes on the SARS-CoV-2 and HIV Viruses PU
23/03/22 Enzolytics : Highlights the Introduction of IPF Immune(TM) as CRN Data Shows Record-Breaking Number of Americans Use Dietary Supplements PU
16/03/22 Enzolytics : SHARE ISSUANCE HISTORY AND DILUTION PU
20/07/21 Enzolytics : Enzolytics, Inc. AQ
Aucun résultat pour cette recherche